Live from the NIH registry
Studies recruiting near Laredo right now
Top 23 of 21 recruiting studies, sorted by proximity — each links to its official registry page
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: City of Hope Medical Center
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: NRG Oncology
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Laguna Clinical Research Associates, LLC — Laredo, Texas (4.1 mi)
· Sponsor: CSL Behring
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Colorectal Cancer, CRC (Colorectal Cancer)
Phase 2
Interventional 136 participants sought
NGM Clinical Study Site — Laredo, Texas (4.1 mi)
· Sponsor: NGM Biopharmaceuticals, Inc
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Hypertension, Acute Severe Hypertension
Phase 2
Interventional 140 participants sought
Laguna Clinical Research Associates — Laredo, Texas (4.1 mi)
· Sponsor: Kardigan, Inc.
Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies
First Episode Psychosis (FEP)
N/A
Interventional 60 participants sought
Border Region Behavioral Health Care — Laredo, Texas (4.1 mi)
· Sponsor: Boston University Charles River Campus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Laredo Medical Center — Laredo, Texas (4.1 mi)
· Sponsor: Stryker Instruments
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
Phase 1, Phase 2
Interventional 92 participants sought
Laguna Clinical Research Associates — Laredo, Texas (4.1 mi)
· Sponsor: Aminex Therapeutics, Inc.
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract
Age Related Cataracts
Phase 2
Interventional 40 participants sought
Valley Retina Institute P.A. — Laredo, Texas (4.1 mi)
· Sponsor: Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Laredo, Texas (4.1 mi)
· Sponsor: Alnylam Pharmaceuticals
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Cancer Weight Loss
Phase 2
Interventional 120 participants sought
Laguna Clinical Research Associates — Laredo, Texas (4.1 mi)
· Sponsor: Endevica Bio
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Phase 1, Phase 2
Interventional 52 participants sought
Doctors Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: SynDevRx, Inc.
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Aeres Clinical Research — Laredo, Texas (4.1 mi)
· Sponsor: Cleerly, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Laguna Clinical Research Associates LLC ( Site 0068) — Laredo, Texas (4.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9901 — Laredo, Texas (4.1 mi)
· Sponsor: Anthos Therapeutics, Inc.
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Doctor's Hospital of Laredo — Laredo, Texas (4.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Advanced Spine Pain Solutions — Laredo, Texas (4.1 mi)
· Sponsor: Boston Scientific Corporation
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
Phase 1, Phase 2
Interventional 796 participants sought
Oncology and Hematology of South Texas, PA — Laredo, Texas (4.1 mi)
· Sponsor: DualityBio Inc.
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Oncology and Hematology of South Texas - 1165 — Laredo, Texas (4.1 mi)
· Sponsor: OncoC4, Inc.
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Coronavirus Disease (COVID-19)
Phase 3
Interventional 3,082 participants sought
Andres Garcia Zuniga, M.D., P.A. ( Site 3782) — Laredo, Texas (4.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Aeres Clinical Research — Laredo, Texas (4.1 mi)
· Sponsor: Novo Nordisk A/S
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 630 participants sought
Local Institution - 0652 — Laredo, Texas (4.1 mi)
· Sponsor: Mirati Therapeutics Inc.